FDA inspection
Sartorius Korea Biotech Company Limited: FDA inspection ending May 20, 2022
FDA inspection 1169893 · Voluntary Action Indicated (VAI) · Seongnam
Key facts
| Inspection ID | 1169893 |
|---|---|
| Firm | Sartorius Korea Biotech Company Limited |
| FEI number | 3020614848 |
| Address | 712 22, Daewangpangyo-Ro, Beon-Gil, Bundang |
| City | Seongnam |
| Fiscal year | 2022 |
| Inspection end date | May 20, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data